clovamide and Parkinson-Disease--Secondary

clovamide has been researched along with Parkinson-Disease--Secondary* in 1 studies

Other Studies

1 other study(ies) available for clovamide and Parkinson-Disease--Secondary

ArticleYear
Synthesis and biological evaluation of clovamide analogues as potent anti-neuroinflammatory agents in vitro and in vivo.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    A series of clovamide analogues, namely, 1a-13a and 1b-13b, was synthesized and evaluated for their anti-neuroinflammatory activities using BV-2 microglia cells. Among these compounds, six (1b, 4b-8b) showed NO inhibition with no or weak cytotoxicity (CC

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Humans; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Neuroprotective Agents; Nitric Oxide Synthase Type II; Parkinson Disease, Secondary; Tyrosine

2018